Nasdaq:QNTM – SPAC Feed

CA74764Y2050
CNSX:QNTM
Frankfurt:0K91
Nasdaq:QNTM

February 6, 2025

Quantum Biopharma Licensee Celly Nutrition Retains Leading New York Investment Bank to Advise on Capital Raise and Possible Initial Public Offering Following Highly Positive Results from unbuzzd™ Clinical Study

QUANTUM BIOPHARMA PARTNER CELLY NUTRITION RETAINS LEADING NEW YORK INVESTMENT BANK TO ADVISE ON CAPITAL RAISE AND POSSIBLE INITIAL PUBLIC OFFERING FOLLOWIN Source: Quantum Biopharma…

By sf-admin